Showing 1 - 10 of 65
challenges of measuring an increasingly dynamic illicit drug market, while building on the positive work in the EU Member States …
Persistent link: https://www.econbiz.de/10015287327
provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA drug …
Persistent link: https://www.econbiz.de/10015287722
Drug markets can be seen from the perspective of supply and demand. Market-related indicators, therefore, particularly … market-related harms has been identified as a priority (Council Conclusions, 2013). The EMCDDA has developed a conceptual …
Persistent link: https://www.econbiz.de/10015288084
estimate of high-risk opioid use in Europe based on the most recent data collected until 2016. …
Persistent link: https://www.econbiz.de/10015288091
Comparable and reliable data about the number and characteristics of people entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatment entrants through the Treatment demand indicator...
Persistent link: https://www.econbiz.de/10015288092
High-risk drug use is one of the major causes of avoidable mortality in Europe, both directly through overdose and …
Persistent link: https://www.econbiz.de/10015288099
established illicit drugs, such as heroin, cocaine and cannabis, and the rapidly evolving market for new psychoactive substances …
Persistent link: https://www.econbiz.de/10015288123
looks at the future direction of cannabis legislation in Europe. …
Persistent link: https://www.econbiz.de/10015290058
provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA drug …
Persistent link: https://www.econbiz.de/10015290459
looks at the future direction of cannabis legislation in Europe. …
Persistent link: https://www.econbiz.de/10015290511